NovaBay Pharmaceuticals (NYSE: NBY) is a biopharmaceutical company that develops and commercializes non-antibiotic anti-infective products for the eye care market in the United States. Its commercial products include the Neutrox family of products, Avenova for the eye care market; NovaClear intelli-Case, a device for soft and rigid gas permeable contact lenses; Neutrophase for wound care; CelleRx for the dermatology market; and Aganocide compounds patented synthetic molecules with a range of spectrum of activity against bacteria, viruses, and fungi to mimic the mechanism of action against infections with a low likelihood of developing bacterial and viral resistance. For more information, visit the company’s website at www.novabaypharma.com.
About NetworkNewsWire
NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, visit https://www.networknewswire.com
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.com